Skip to content

WHITE PAPER SERIES

White Papers

In-depth frameworks, technical monographs and practical guidance on pharmacovigilance, responsible AI, and regulatory compliance.

Schilling Vigilance White Paper Series

Independent White Papers on Pharmacovigilance, PSMF Governance and AI in Life Sciences

The Schilling Vigilance White Paper Series provides independent analysis of pharmacovigilance governance, PSMF management, inspection readiness and the responsible use of artificial intelligence in regulated environments.

Each paper is authored by Reinhold Schilling and is available free of charge.

White paper library

Showing 12 white papers

Thumbnail for White Paper No. 1: Pharmacovigilance Across Multiple Marketing Authorisation Holders

Schilling Vigilance

White Paper No. 1

White Paper No. 1

Rev. 0

Pharmacovigilance Across Multiple Marketing Authorisation Holders

Five governance decisions that determine inspection readiness in the EU/EEA, the United Kingdom and Switzerland.

Published
September 2026
Category
Pharmacovigilance Governance
  • Pharmacovigilance
  • Governance
  • Inspection Readiness
Thumbnail for White Paper No. 2: The AI-Enabled PSMF

Schilling Vigilance

White Paper No. 2

White Paper No. 2

Rev. 0

The AI-Enabled PSMF

From Periodic Document Maintenance to a Controlled Digital Representation of the Pharmacovigilance System.

Published
September 2026
Category
AI & Pharmacovigilance
  • Artificial Intelligence
  • PSMF
  • Pharmacovigilance
Thumbnail for White Paper No. 3: EU PSMF and UK PSMF

Schilling Vigilance

White Paper No. 3

White Paper No. 3

Rev. 0

EU PSMF and UK PSMF

What start-ups really need to do.

Published
September 2026
Category
PSMF
  • PSMF
  • Regulatory Compliance
  • Pharmacovigilance
Thumbnail for White Paper No. 4: Pharmacovigilance in a Multi-Entity Marketing Authorisation Structure

Schilling Vigilance

White Paper No. 4

White Paper No. 4

Rev. 0

Pharmacovigilance in a Multi-Entity Marketing Authorisation Structure

Five decisions that determine inspection readiness across the EU, the United Kingdom and Switzerland.

Published
September 2026
Category
Pharmacovigilance Governance
  • Pharmacovigilance
  • Governance
  • Inspection Readiness
Thumbnail for White Paper No. 5: Controlled Digital Intake

Schilling Vigilance

White Paper No. 5

White Paper No. 5

Rev. 0

Controlled Digital Intake

From social-media message to controlled action using n8n and bounded AI.

Published
24 September 2026
Category
AI & Pharmacovigilance
  • Artificial Intelligence
  • Pharmacovigilance
  • Digital Intake
Thumbnail for White Paper No. 6: Beyond “Human in the Loop”

Schilling Vigilance

White Paper No. 6

White Paper No. 6

Rev. 0

Beyond “Human in the Loop”

Designing Effective Human Oversight in Pharmacovigilance AI

Published
25 September 2026
Category
AI & Pharmacovigilance
  • Artificial Intelligence
  • Human Oversight
  • Pharmacovigilance
Thumbnail for White Paper No. 7: Changing the Engine While Flying

Schilling Vigilance

White Paper No. 7

White Paper No. 7

Rev. 0

Changing the Engine While Flying

Maintaining the Validated State When AI Models Change in Pharmaceutical GxP Systems.

Published
25 September 2026
Category
AI & Pharmacovigilance
  • Artificial Intelligence
  • GxP
  • Validation
  • Pharmacovigilance
Thumbnail for White Paper No. 8: Qualifying AI-Enabled Pharmacovigilance Service Providers

Schilling Vigilance

White Paper No. 8

White Paper No. 8

Rev. 0

Qualifying AI-Enabled Pharmacovigilance Service Providers

A Practical Due-Diligence and Oversight Framework.

Published
25 September 2026
Category
AI & Pharmacovigilance
  • Artificial Intelligence
  • Due Diligence
  • Pharmacovigilance
  • Service Providers
Thumbnail for White Paper No. 9: One Message, Three Processes

Schilling Vigilance

White Paper No. 9

White Paper No. 9

Rev. 0

One Message, Three Processes

Managing the Interfaces Between Pharmacovigilance, Product Complaints and Medical Information.

Published
26 September 2026
Category
Pharmacovigilance Governance
  • Pharmacovigilance
  • Product Complaints
  • Medical Information
  • Day Zero
  • Reconciliation
Thumbnail for White Paper No. 10: From AI Pilot to GxP Production

Schilling Vigilance

White Paper No. 10

White Paper No. 10

Rev. 0

From AI Pilot to GxP Production

A Stage-Gated Implementation Model for Pharmacovigilance.

Published
28 September 2026
Category
AI & Pharmacovigilance
  • Artificial Intelligence
  • GxP
  • Implementation
  • Pharmacovigilance

White Paper No. 11

Reserved

White Paper No. 11 will not be published. It is provided exclusively to a conference beginning in 2027.

Thumbnail for White Paper No. 12: Signal Detection in the Age of Artificial Intelligence

Schilling Vigilance

White Paper No. 12

White Paper No. 12

Version 1.0

Signal Detection in the Age of Artificial Intelligence

From Disproportionality Screening to Human-Governed, AI-Augmented Signal Management

Published
September 2026
Category
AI & Pharmacovigilance
  • Artificial Intelligence
  • Signal Detection
  • Signal Management
  • Pharmacovigilance
Thumbnail for White Paper No. 13: Inspection-Ready AI in Pharmacovigilance

Schilling Vigilance

White Paper No. 13

White Paper No. 13

Inspection-Ready AI in Pharmacovigilance

Governance, lifecycle assurance and transaction-level traceability

Published
1 October 2026
Category
AI & Pharmacovigilance
  • Artificial Intelligence
  • Inspection Readiness
  • GxP
  • Pharmacovigilance